In Section A, contributors will receive unique doses and schedules of oral ABBV-744 pill to establish Secure dosing routine. Supplemental participants might be enrolled in the recognized monotherapy dosign routine. In Section B, contributors will receive oral ruxolitinib and ABBV-744 might be given as "incorporate-on" therapy. In Section C, members https://abbv-744-brd4-inhibition89179.frewwebs.com/32662256/considerations-to-know-about-is-abbv-744-effective-for-hematologic-cancers